幹細胞檢測市場規模、佔有率、成長分析、按產品類型、按檢測類型、按應用、按最終用戶、按地區 - 行業預測，2024-2031

2022年全球幹細胞檢測市場規模為19億美元，從2023年的22.4億美元成長到2031年的82.4億美元，複合年成長率預計將成長17.7%。

由於難以獲得的細胞類型的穩定可用性和生理相關模型的開發，幹細胞檢測市場正在經歷顯著成長。醫療基礎設施和技術創新的最新進展正在改變治療通訊協定並促進新治療方法和學名藥的發現。基於細胞的測定擴大用於評估重要參數，例如細胞活力、細胞毒性和衰老，特別是在高通量篩檢環境中。此外，對幹細胞檢測的投資增加和研究舉措的加強正在支持更安全的治療方法的出現。醫學研究和藥物發現對幹細胞檢測的需求不斷成長，加上製藥業的擴張，繼續推動這個充滿活力的市場向前發展。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 監管環境
• 專利分析
• 案例研究

按產品類型和複合年成長率分類的幹細胞檢測市場規模（2024-2031）

• 市場概況
• 裝置
  • 流式細胞儀
  • 微電極陣列
  • 細胞成像系統
• 消耗品
  • 試劑和套件
  • 微孔盤
  • 檢測試劑套件

幹細胞檢測市場規模：依檢測類型及複合年成長率（2024-2031）

• 市場概況
• 細胞活力和毒性測定
  • MTT試驗
  • 台盼藍排除試驗
• 細胞鑑定測試
  • 免疫細胞化學
  • 流式細胞技術
• 細胞增殖測試
  • Brdu 測定
  • 教育分析
• 細胞分化測試
  • 鹼性磷酸酶測試
  • 螢光測定
• 其他
  • 細胞凋亡檢測
  • 移動測試

幹細胞檢測市場規模：依應用和複合年成長率（2024-2031）

• 市場概況
• 再生醫學和治療方法的發展
  • 神經病學
  • 腫瘤學
  • 心血管
• 藥物發現與開發
  • 毒性試驗
  • 功效測試
• 臨床調查
  • 疾病模型
  • 幹細胞表徵

幹細胞檢測市場規模：依最終用戶和複合年成長率（2024-2031）

• 市場概況
• 製藥和生物技術公司
  • 藥物開發
  • 品管
• 學術研究所
  • 基礎調查
  • 轉化研究
• 合約調查機構（Cros）
  • 臨床前研究
  • 臨床試驗

幹細胞檢測市場規模及複合年成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Thermo Fisher Scientific Inc.（USA）
• Merck KGaA（Germany）
• Danaher Corporation（USA）
• Becton, Dickinson and Company（USA）
• Bio-Rad Laboratories, Inc.（USA）
• Promega Corporation（USA）
• Bio-Techne Corporation（USA）
• FUJIFILM Holdings Corporation（Japan）
• Charles River Laboratories（USA）
• HemoGenix, Inc.（USA）
• Lonza Group（Switzerland）
• Takara Bio Inc.（Japan）
• Creative Bioarray（USA）
• AAT Bioquest, Inc.（USA）
• BPS Bioscience, Inc.（USA）
• Enzo Biochem, Inc.（USA）
• PromoCell GmbH（Germany）
• Biotium, Inc.（USA）
• Geno Technology, Inc.（USA）

結論和建議

Global Stem Cell Assay Market size was valued at USD 1.9 billion in 2022 and is poised to grow from USD 2.24 billion in 2023 to USD 8.24 billion by 2031, growing at a CAGR of 17.7% during the forecast period (2024-2031).

The stem cell assay market is experiencing significant growth driven by the consistent availability of hard-to-source cell types and the development of physiologically relevant models. Recent advancements in medical infrastructure and technology innovations have transformed treatment protocols and facilitated the discovery of novel therapies and generic drugs. Cell-based assays are increasingly employed to evaluate key parameters such as cell viability, cytotoxicity, and senescence, particularly within high-throughput screening environments. Furthermore, heightened investment and intensified research initiatives in stem cell assays have fostered the emergence of safer treatment options. The rising demand for stem cell-based assays in medical research and drug discovery, coupled with the expansion of the pharmaceutical sector, continues to propel this dynamic market forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Stem Cell Assay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Stem Cell Assay Market Segmental Analysis

Global Stem Cell Assay Market is segmented by product type, assay type, application, end-user and region. Based on product type, the market is segmented into instruments and consumables. Based on assay type, the market is segmented into cell viability & toxicity assays, cell identification assays, cell proliferation assays, cell differentiation assays and others. Based on application, the market is segmented into regenerative medicine & therapy development, drug discovery & development and clinical research. Based on end-user, the market is segmented into pharmaceutical & biotechnology companies, academic & research institutes and contract research organizations (CROs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Stem Cell Assay Market

The global stem cell assay market is fundamentally influenced by a rising health consciousness among the population and ongoing population growth. While the COVID-19 pandemic posed significant challenges for various sectors, the stem cell assay market demonstrated resilience, with key players maintaining their product offerings despite the downturn. The continuous advancements in stem cell assays not only address the complexities of global demand but also enhance the quality of care provided to patients. As health awareness escalates, the demand for innovative stem cell assays is likely to grow, positioning the market for sustained development in the future.

Restraints in the Global Stem Cell Assay Market

The Global Stem Cell Assay market faces several restraints, one of the most significant being the high cost of raw materials. This economic challenge affects various industrial sectors, hindering their ability to maintain sustainable production operations. The elevated expenses associated with sourcing essential materials can lead to increased pricing for finished products, ultimately impacting market growth and accessibility. Companies in the stem cell research and therapeutic fields may struggle to balance the need for quality inputs with budget constraints, potentially limiting innovation and the advancement of stem cell technologies. Therefore, addressing this financial barrier is crucial for the market's overall development.

Market Trends of the Global Stem Cell Assay Market

The Global Stem Cell Assay market is witnessing a notable upward trend, driven by the rising emphasis on personalized medicine and regenerative therapies. This greater focus has catalyzed the demand for stem cell assays, essential for streamlining drug discovery and development processes. Furthermore, significant technological advancements and the integration of automation have markedly improved the efficiency and accuracy of these assays, resulting in superior research outcomes and cost-effectiveness. As pharmaceutical companies and research institutions increasingly prioritize these innovative approaches, the stem cell assay market is poised for substantial growth, reflecting broader shifts toward precision and tailored healthcare solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Stem Cell Assay Market Size by Product Type & CAGR (2024-2031)

• Market Overview
• Instruments
  • Flow Cytometers
  • Microelectrode Arrays
  • Cell Imaging Systems
• Consumables
  • Reagents & Kits
  • Microplates
  • Assay Kits

Global Stem Cell Assay Market Size by Assay Type & CAGR (2024-2031)

• Market Overview
• Cell Viability & Toxicity Assays
  • Mtt Assay
  • Trypan Blue Exclusion Assay
• Cell Identification Assays
  • Immunocytochemistry
  • Flow Cytometry
• Cell Proliferation Assays
  • Brdu Assay
  • Edu Assay
• Cell Differentiation Assays
  • Alkaline Phosphatase Assay
  • Immunofluorescence Assay
• Others
  • Apoptosis Assays
  • Migration Assays

Global Stem Cell Assay Market Size by Application & CAGR (2024-2031)

• Market Overview
• Regenerative Medicine & Therapy Development
  • Neurology
  • Oncology
  • Cardiovascular
• Drug Discovery & Development
  • Toxicology Testing
  • Efficacy Testing
• Clinical Research
  • Disease Modeling
  • Stem Cell Characterization

Global Stem Cell Assay Market Size by End-User & CAGR (2024-2031)

• Market Overview
• Pharmaceutical & Biotechnology Companies
  • Drug Development
  • Quality Control
• Academic & Research Institutes
  • Basic Research
  • Translational Research
• Contract Research Organizations (Cros)
  • Preclinical Studies
  • Clinical Trials

Global Stem Cell Assay Market Size & CAGR (2024-2031)

• North America (Product Type, Assay Type, Application, End-User)
  • USA
  • Canada
• Europe (Product Type, Assay Type, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Assay Type, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Assay Type, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Assay Type, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HemoGenix, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Bioarray (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AAT Bioquest, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BPS Bioscience, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enzo Biochem, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PromoCell GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotium, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Geno Technology, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations